TCGX
Chen Yu is a seasoned board member with extensive experience in the pharmaceutical and biotechnology sectors, currently serving on the boards of multiple companies including Pathalys Pharma, LB Pharma, ADARx Pharmaceuticals Inc., Alkeus Pharmaceuticals, and Upstream Bio since 2021. In addition, Chen Yu holds a founding managing partner position at TCG X. Educational background includes an MBA from Stanford University Graduate School of Business, a medical education from Stanford University School of Medicine, and a BA in Biology from Harvard University. Notably, Chen Yu has contributed to the board of Structure Therapeutics and Tarsus until both companies achieved IPO status.
This person is not in any teams
This person is not in any offices
TCGX
TCGX is a registered investment advisor based in Palo Alto, California. TCGX invests in both private and public opportunities, focusing on innovative pre-IPO and public drug discovery companies. We invest in visionary entrepreneurs leveraging recent scientific breakthroughs to develop transformative medicines.